Pleural Effusion — SAQ

Stem

A candidate is asked to manage a classic presentation of Pleural Effusion in an exam setting. Use precise definitions, scores, doses, and decision thresholds.

Core knowledge (model answer backbone)

Pleural effusion is an accumulation of fluid in the normally near-dry pleural space. It is classified by Light's criteria (1972) as a transudate (systemic cause: heart failure, cirrhosis, nephrotic syndrome, peritoneal dialysis, myxoedema, pulmonary embolism) or an exudate (local pleural disease: parapneumonic, malignancy, tuberculosis, pulmonary embolism, autoimmune, pancreatitis, chylothorax, haemothorax). Diagnosis rests on chest X-ray (blunted costophrenic angle over 200 mL, meniscus sign, mediastinal shift), thoracic ultrasound (loculation, septation, guidance) and diagnostic thoracentesis with pleural fluid analysis (protein, LDH, glucose, pH, cell count, Gram stain and culture, cytology, ADA, amylase, triglycerides, NT-proBNP). Treatment is cause-specific; therapeutic thoracentesis, small-bore Seldinger chest drain, talc pleurodesis and indwelling pleural catheter are the procedural pillars.

Red flags

• Tension pleural effusion — severe respiratory compromise with hypotension and tracheal deviation away from the side; emergency needle decompression then intercostal drain
• Empyema — infected pleural fluid (frank pus, pH under 7.2, glucose under 3.3 mmol/L, positive Gram stain); requires immediate chest drain plus intravenous antibiotics, intrapleural tPA plus DNase if loculated, surgical decortication if failed
• Massive haemothorax (over 1500 mL initial drainage or over 200 mL per hour ongoing) — large-bore intercostal drain, resuscitation, thoracic surgery referral
• Chylothorax (pleural fluid triglycerides over 1.24 mmol/L or 110 mg/dL) — investigate thoracic duct injury, lymphoma, post-surgical leak; consider medium-chain triglyceride diet, octreotide, thoracic duct ligation

High-yield structure examiners expect

Cover: Overview & Definition, Classification, Epidemiology & Risk Factors, Pathophysiology, Clinical Presentation, Differential Diagnosis.

Key doses / thresholds (from topic teaching)

• glucose under 3.3 mmol/L or the fluid is frankly purulent**; u
• around 5 to 15 mL in an adult), continuously generated by
• d by the parietal lymphatics at a rate of 0.01 mL/kg/h, with a maximal lymphatic clearanc
• e of roughly 0.4 mL/kg/h — a generous reserve that must be
• serum-pleural albumin gradient over 1.2 g/dL; NT-proBNP over 1500 ng/L"] },
• triglycerides over 1.24 mmol/L) and haemothorax"] }

Questions

a) Define the condition and give the most important classification or severity framework used in exams. (3 marks)

• Clear one-line definition matching standard teaching.
• Named classification / stages / types with discriminating features.
• One sentence on why classification changes management.

b) Outline pathophysiology in a mechanism chain that explains the main clinical features. (3 marks)

• Initiating insult → intermediate pathway → end-organ effect.
• Link at least two symptoms/signs to mechanism.
• Mention one complication pathway (e.g. shock, perforation, herniation, arrhythmia).

c) List discriminating clinical features and bedside assessment. (3 marks)

• Classic presentation plus one atypical group (elderly, pregnancy, child, immunocompromised).
• Named signs/manoeuvres if relevant.
• What must never be missed on exam/bedside (pregnancy test, airway, glucose, etc.).

d) Investigations with thresholds and one named score if applicable. (3 marks)

• First-line tests and what positive findings mean.
• Gold-standard or definitive investigation when needed.
• Score components reproduced exactly if a named score is standard for this topic.

e) Immediate resuscitation and definitive management with doses where standard. (3 marks)

• ABC / time-critical steps first.
• First-line drug(s) with agent + dose + route (or procedure steps).
• Escalation triggers (theatre, ICU, thrombolysis window, antidote, etc.).
• Disposition and safety-netting.

Marking tips

Full marks require specificity (numbers, names, doses) not generic "give antibiotics/fluids." Regional practice (ICMR / NICE / AHA) may be cited as alternative where relevant.